Cargando…

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY ANSWER: Oral dydrogesterone demonstrated non-inferiority to MVP gel for the presence of fetal heartbeats at 12 weeks of gestation (non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griesinger, Georg, Blockeel, Christophe, Sukhikh, Gennady T, Patki, Ameet, Dhorepatil, Bharati, Yang, Dong-Zi, Chen, Zi-Jiang, Kahler, Elke, Pexman-Fieth, Claire, Tournaye, Herman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238366/ https://www.ncbi.nlm.nih.gov/pubmed/30304457 http://dx.doi.org/10.1093/humrep/dey306

Ejemplares similares

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
por: Vidal, Angela, et al.
Publicado: (2023)

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Luteal Phase Support in IVF: Comparison Between Evidence-Based Medicine and Real-Life Practices
por: Di Guardo, Federica, et al.
Publicado: (2020)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
por: Doblinger, Jakob, et al.
Publicado: (2016)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review
por: Muneeba, Shaikh, et al.
Publicado: (2023)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
por: Simon, Virginie, et al.
Publicado: (2022)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
por: Sofuoglu, Kenan, et al.
Publicado: (2015)

Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial
por: Khosravi, Donya, et al.
Publicado: (2015)

Progesterone signaling in the regulation of luteal steroidogenesis
por: Yakin, Kayhan, et al.
Publicado: (2023)

Progesterone Hypersensitivity: A Challenge for Luteal Support
por: Gupta, Astha, et al.
Publicado: (2018)

Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates
por: Gari, Salwa, et al.
Publicado: (2022)

The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis
por: Lee, Hee Joong, et al.
Publicado: (2017)

The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels
por: Metello, Jose, et al.
Publicado: (2022)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Optimisation of the follicular phase in IVF/ICSI
por: Blockeel, C.
Publicado: (2012)

Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny
por: Jeschke, Laura, et al.
Publicado: (2021)

Astaxanthin increases progesterone production in cultured bovine luteal cells
por: KAMADA, Hachiro, et al.
Publicado: (2017)

Mid-Luteal Progesterone Is Inversely Associated with Premenstrual Food Cravings
por: Hamidovic, Ajna, et al.
Publicado: (2023)

Low Testosterone and Semen Parameters in Male Partners of Infertile Couples Undergoing IVF with a Total Sperm Count Greater than 5 Million
por: Di Guardo, Federica, et al.
Publicado: (2020)

Is the psychological stress related to the impact of IVF/ICSI and the INVO intravaginal device significantly different?
por: Portella, Jimmy, et al.
Publicado: (2014)

Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates
por: Thomsen, Lise Haaber, et al.
Publicado: (2018)

Comparison of Dydrogesterone and GnRH Antagonists for Prevention of Premature LH Surge in IVF/ICSI Cycles: A Randomized Controlled Trial
por: Hossein Rashidi, Batool, et al.
Publicado: (2020)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)

Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage
por: Parveen, Rashida, et al.
Publicado: (2021)

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment
por: Heine, Polly, et al.
Publicado: (2017)

Intravaginal administration of progesterone using a new technique for sustained drug release in goats
por: ENDO, Natsumi, et al.
Publicado: (2020)

Clinical Re-evaluation on Bioequivalence and Relative Bioavailability of Micronized Progesterone Hard Capsule (Yimaxin) and Micronized Progesterone Soft Capsule (Utrogestan) under Vaginal and Oral Administration Routes
por: Wang, Hanbi, et al.
Publicado: (2021)

Effect of oxytocin infusion on luteal blood flow and progesterone secretion in dairy cattle
por: Brozos, Christos N., et al.
Publicado: (2012)

Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
por: Palomba, Stefano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_29tfcu7e5l0b218stmb4qo0dto